Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S4 from Vascular Normalization Augments the Antitumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors
  1. Home
  2. Publications
  3. Supplementary Figure S4 from Vascular Normalization Augments the Antitumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors

Supplementary Figure S4 from Vascular Normalization Augments the Antitumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors

Authors:
  • MWMin Wang
    Min Wang
  • YCYanxing Chen
    Yanxing Chen
  • LTLin Tian
    Lin Tian
  • CWChenyi Wu
    Chenyi Wu
  • JCJiaying Chen
    Jiaying Chen
  • JHJiajia Hu
    Jiajia Hu
  • RHRunjie Huang
    Runjie Huang
  • YWYingnan Wang
    Yingnan Wang
  • JZJinling Zhang
    Jinling Zhang
  • XOXiao-Jie Ouyang
    Xiao-Jie Ouyang
  • LWLiqin Wang
    Liqin Wang
  • YJYing Jin
    Ying Jin

Open Access
Publisher website
Google Scholar
  • 4 September 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2159-8290.30050802
Abstract
HDAC inhibitor promotes the expression of VEGFa in macrophage
Keywords
  • GASTROINTESTINAL CANCERS
  • IMMUNOTHERAPY
  • COMBINATION IMMUNOTHERAPY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.